End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
19.50 CNY | -0.76% |
|
-1.47% | +6.15% |
Capitalization | 8.87B 1.23B 1.05B 981M 909M 1.69B 106B 1.89B 11.75B 4.47B 49.59B 4.63B 4.53B 181B | P/E ratio 2025 * |
20.2x | P/E ratio 2026 * | 17.3x |
---|---|---|---|---|---|
Enterprise value | 9.48B 1.32B 1.13B 1.05B 972M 1.81B 113B 2.02B 12.56B 4.78B 53.02B 4.95B 4.85B 193B | EV / Sales 2025 * |
2.62x | EV / Sales 2026 * | 2.13x |
Free-Float |
51.84% | Yield 2025 * |
2.29% | Yield 2026 * | 2.81% |
More valuation ratios
* Estimated data
More news
1 day | -0.76% | ||
1 week | -1.47% | ||
Current month | +0.41% | ||
1 month | -7.32% | ||
3 months | +3.67% | ||
6 months | +11.30% | ||
Current year | +6.15% |
1 week | 19.45 | ![]() | 20.19 |
1 month | 18.98 | ![]() | 21.55 |
Current year | 16.08 | ![]() | 28.9 |
1 year | 11.25 | ![]() | 28.9 |
3 years | 11.25 | ![]() | 28.9 |
5 years | 11.25 | ![]() | 44.41 |
10 years | 6.3 | ![]() | 44.41 |
Manager | Title | Age | Since |
---|---|---|---|
Shou Jun Li
CEO | Chief Executive Officer | 62 | 2008-05-11 |
Chang Chang Li
DFI | Director of Finance/CFO | 50 | 2022-04-27 |
Xiu Tong Zhu
PRN | Corporate Officer/Principal | 44 | 2020-10-26 |
Director | Title | Age | Since |
---|---|---|---|
Shou Jun Li
CHM | Chairman | 62 | 2008-05-11 |
Zhong Hua Zhou
CHM | Chairman | 62 | 2018-12-23 |
Lei Xu
BRD | Director/Board Member | 52 | 2019-12-24 |
Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
---|---|---|---|---|---|---|
-0.76% | -1.47% | +48.85% | +9.92% | 1.25B | ||
+0.30% | -0.58% | -9.78% | -11.07% | 70.25B | ||
+0.20% | +2.43% | +6.03% | -27.73% | 7.33B | ||
-0.72% | -0.93% | +1.05% | +0.31% | 3.63B | ||
+1.46% | +9.29% | -0.86% | -7.96% | 3.35B | ||
-0.80% | +5.82% | +20.23% | -9.64% | 2.35B | ||
+4.22% | +17.92% | +79.17% | +60.56% | 1.22B | ||
-0.95% | +0.14% | +4.12% | -41.50% | 1.05B | ||
+2.67% | +3.63% | -18.35% | -35.40% | 1.04B | ||
-0.31% | +1.46% | +18.68% | -38.27% | 1.03B | ||
Average | +0.53% | +2.57% | +14.91% | -10.08% | 9.25B | |
Weighted average by Cap. | +0.31% | +0.07% | -4.68% | -11.49% |
2025 * | 2026 * | |
---|---|---|
Net sales | 3.61B 503M 430M 400M 371M 689M 43.13B 770M 4.79B 1.82B 20.22B 1.89B 1.85B 73.63B | 4.21B 587M 501M 466M 432M 803M 50.27B 898M 5.58B 2.12B 23.56B 2.2B 2.15B 85.82B |
Net income | 450M 62.66M 53.48M 49.77M 46.13M 85.75M 5.37B 95.88M 596M 227M 2.52B 235M 230M 9.17B | 525M 73.09M 62.38M 58.06M 53.81M 100M 6.26B 112M 696M 265M 2.94B 274M 268M 10.69B |
Net Debt | 612M 85.27M 72.78M 67.74M 62.78M 117M 7.31B 130M 811M 309M 3.42B 320M 313M 12.47B | 101M 14.11M 12.04M 11.21M 10.39M 19.31M 1.21B 21.59M 134M 51.07M 567M 52.91M 51.8M 2.06B |
More financial data
* Estimated data
Employees
2,900
Sector
Pharmaceuticals
Calendar
Aug. 25
- Q2 2025 Earnings Release
Date | Price | Change | Volume |
---|---|---|---|
25-07-09 | 19.50 ¥ | -0.76% | 6,867,602 |
25-07-08 | 19.65 ¥ | -1.06% | 11,562,310 |
25-07-07 | 19.86 ¥ | +0.71% | 8,648,118 |
25-07-04 | 19.72 ¥ | -0.35% | 9,188,400 |
25-07-03 | 19.79 ¥ | +0.97% | 10,781,300 |
End-of-day quote Shenzhen S.E., July 08, 2025
More quotesSell
Buy

Mean consensus
BUY
Number of Analysts
7
Last Close Price
19.50CNY
Average target price
26.29CNY
Spread / Average Target
+34.82%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- 300119 Stock
Select your edition
All financial news and data tailored to specific country editions